Global X - Genomics & Biotechnology ETF
ETFYour view on GNOM
Global X - Genomics & Biotechnology ETF
ETFGlobal XSentiment
AUM (USD)
$93.74M
Expense Ratio
0.5%
Holdings
50
Sentiment
Overview for Global X - Genomics & Biotechnology ETF
- Fund Type
- ETF
- Fund Issuer
- Global X
- Asset Class
- Equity
- Sector
- Financial Services
- Industry
- Asset Management - Global
- Inception Date
- April 5, 2019
- Domicile
- US
- Website
- globalxetfs.com/funds/GNOM
- Fund Type
- ETF
- Fund Issuer
- Global X
- Asset Class
- Equity
- Sector
- Financial Services
- Industry
- Asset Management - Global
- Inception Date
- April 5, 2019
- Domicile
- US
- Website
- globalxetfs.com/funds/GNOM
- Fund Type
- ETF
- Fund Issuer
- Global X
- Asset Class
- Equity
- Sector
- Financial Services
- Industry
- Asset Management - Global
- Inception Date
- April 5, 2019
- Domicile
- US
- Website
- globalxetfs.com/funds/GNOM
About this fund
The Global X Genomics & Biotechnology ETF (GNOM) seeks to provide investment results that correspond generally to the price and yield performance, before fees and expenses, of the Solactive Genomics Index.
GNOM Stock Price
Key Facts
EquityExpense Ratio
0.5%
AUM
$93.74M
Fund Details
Expense Ratio
0.5%
Assets Under Management
$93.74M
NAV
$62.30 USD
Holdings
50
Average Volume
27.0K
Inception Date
April 5, 2019
Asset Class
Equity
Fund Issuer
Global X
Domicile
US
ISIN
US37960A2143
CUSIP
37960A214
NAV Currency
USD
Expense Ratio
0.5%
Assets Under Management
$93.74M
NAV
$62.30 USD
Holdings
50
Average Volume
27.0K
Inception Date
April 5, 2019
Asset Class
Equity
Fund Issuer
Global X
Domicile
US
ISIN
US37960A2143
CUSIP
37960A214
NAV Currency
USD
Latest headlines and company announcements for this company. Press releases and market coverage, newest first.
News
this company valued side by side against its closest peers. Peer-relative multiples and operating metrics, so the valuation is read in the context of its own sector rather than in isolation.